Our Pledge to Nature

Our Pledge to Nature

Protecting the Source of Mytesi

For centuries, traditional healers and ethnobotanical researchers in the Amazonian rainforest have recognized the medicinal properties of Mytesi’s botanical source material.

Mytesi’s active ingredient, crofelemer, is extracted and purified from the red bark sap of the Croton lechleri tree, which is sustainably harvested through a robust reforestation program dedicated to ensuring a high degree of quality, safety, and ecological integrity.1

How does Napo promote sustainability?

The botanical source material for Mytesi is sustainably harvested from Croton lechleri, an abundant, fast-growing Amazonian tree species

For every 1 tree harvested, at least 2 new trees are planted

Since 2001, Napo Pharmaceuticals, the maker of Mytesi, has planted over 800,000 trees

Napo has practiced fair trade with its local and Indigenous partners for over 2 decades, which has provided income-generating opportunities for individuals, communities, and families

Jaguar Health, Mytesi’s parent company, is involved in many environmental efforts.

Jaguar Health, Mytesi’s parent company, is involved in many environmental efforts.

Read More
View Proven Results
The NapoCares™ program offers comprehensive support to help Mytesi patients* start and stay on therapy.
Explore The NapoCares™ Program
*Subject to eligibility. Restrictions apply. Rx only.

Reference: 1. King S. Sustainable harvesting of dragon’s blood (Croton lechleri) in Peru. HerbalGram. 2020;125:44-57.